83763-11-5 Usage
General Description
1-(4-piperidinyl)-1H-benzimidazole is a chemical compound with a molecular formula C14H16N2. It is an organic compound that contains a benzimidazole ring fused to a piperidine ring. 1-(4-piperidinyl)-1H-benzimidazole has been studied for its potential pharmacological properties, including its ability to act as a histamine H3 receptor antagonist. It has also been investigated for its potential use in the treatment of cognitive impairments and neurodegenerative diseases. Additionally, it has shown potential as a therapeutic agent for psychiatric disorders such as schizophrenia. Further research is ongoing to explore the full range of its biological activities and potential medicinal applications.
Check Digit Verification of cas no
The CAS Registry Mumber 83763-11-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,7,6 and 3 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 83763-11:
(7*8)+(6*3)+(5*7)+(4*6)+(3*3)+(2*1)+(1*1)=145
145 % 10 = 5
So 83763-11-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H15N3/c1-2-4-12-11(3-1)14-9-15(12)10-5-7-13-8-6-10/h1-4,9-10,13H,5-8H2
83763-11-5Relevant articles and documents
DIPHENYLBUTYPIPERIDINE AUTOPHAGY INDUCERS
-
Page/Page column 7; 87-90, (2011/12/02)
Autophagy inducing compounds, methods of their preparation and use, and kits containg said compounds are disclosed herein.
Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: Effects of fused heterocycles on antiviral activity and pharmacokinetic properties
Kim, Dooseop,Wang, Liping,Hale, Jeffrey J.,Lynch, Christopher L.,Budhu, Richard J.,MacCoss, Malcolm,Mills, Sander G.,Malkowitz, Lorraine,Gould, Sandra L.,Demartino, Julie A.,Springer, Martin S.,Hazuda, Daria,Miller, Michael,Kessler, Joseph,Hrin, Renee C.,Carver, Gwen,Carella, Anthony,Henry, Karen,Lineberger, Janet,Schleif, William A.,Emini, Emilio A.
, p. 2129 - 2134 (2007/10/03)
A series of 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists containing a variety of fused heterocycles at the 4-position of the piperidine side chain has been discovered, which are orally bioavailable with potent anti-HIV activity.
